Lysosomal Membrane Proteins: Clinical Trials

2 trials of Lysosomal Membrane Proteins, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Recruiting 1

Follow Lysosomal Membrane Proteins: new trials by email Literature Review of Lysosomal Membrane Proteins trials Research Report on Lysosomal Membrane Proteins

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)
Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs) - Recurrent Medulloblastoma
Phase 1Active not recruitingUniversity of Florida242026-04-242026-09-29
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs) - Adult Glioblastoma, High Grade Glioma
Phase 1RecruitingUniversity of Florida282021-12-132026-10-30

Conditions studied

Brain Neoplasms (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Lymphoma, Follicular (1)  ·  Medulloblastoma (1)

Sponsors

University of Florida (2)

Countries

United States (2)

Top investigators

Elias Sayour, MD, PhD (2)  ·  Sabine Mueller, MD, PhD (1)

Results publications

PMID 34101090, PMID 41218853